These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7575694)

  • 1. Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone.
    Blackburn WD; Prupas HM; Silverfield JC; Poiley JE; Caldwell JR; Collins RL; Miller MJ; Sikes DH; Kaplan H; Fleischmann R
    Arthritis Rheum; 1995 Oct; 38(10):1447-56. PubMed ID: 7575694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis treated with tenidap and piroxicam. Clinical associations with cytokine modulation by tenidap.
    Littman BH; Drury CE; Zimmerer RO; Stack CB; Law CG
    Arthritis Rheum; 1995 Jan; 38(1):29-37. PubMed ID: 7818568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial.
    Wylie G; Appelboom T; Bolten W; Breedveld FC; Feely J; Leeming MR; Le Loët X; Manthorpe R; Marcolongo R; Smolen J
    Br J Rheumatol; 1995 Jun; 34(6):554-63. PubMed ID: 7543348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled study.
    Prupas HM; Loose LD; Spindler JS; Dietz AJ; Gum OB; Weisman MH; Gordon G; Wolf RE; Turner RA; Collins RL; Germain BF; Katz P; Ballou SP; Wolfe F; Daniels JC; April PA; Willkens RF; Pariser K; Hepburn B; Zizic TM; Ting N; Mehrban M
    Scand J Rheumatol; 1996; 25(6):345-51. PubMed ID: 8996468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug.
    Loose LD; Sipe JD; Kirby DS; Kraska AR; Weiner ES; Shanahan WR; Leeming MR; Farrow P; Stack CB; Ting N
    Br J Rheumatol; 1993 Jun; 32 Suppl 3():19-25. PubMed ID: 7685226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis.
    Breedveld F
    Scand J Rheumatol Suppl; 1994; 100():31-44. PubMed ID: 7532319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
    Furst DE; Lindsley H; Baethge B; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D
    Arthritis Rheum; 1999 Feb; 42(2):357-65. PubMed ID: 10025931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenidap reduces the level of interleukin 1 receptors and collagenase expression in human arthritic synovial fibroblasts.
    Martel-Pelletier J; Mineau F; Tardif G; Fernandes JC; Ranger P; Loose L; Pelletier JP
    J Rheumatol; 1996 Jan; 23(1):24-31. PubMed ID: 8838504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
    Visvanathan S; Wagner C; Rojas J; Kay J; Dasgupta B; Matteson EL; Mack M; Baker DG; Rahman MU
    J Rheumatol; 2009 Jul; 36(7):1371-9. PubMed ID: 19487269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arthroscopic evaluation of potential structure-modifying drug in osteoarthritis of the knee. A multicenter, randomized, double-blind comparison of tenidap sodium vs piroxicam.
    Ayral X; Mackillop N; Genant HK; Kirkpatrick J; Beaulieu A; Pippingskiöld P; Will RK; Alava S; Dougados M
    Osteoarthritis Cartilage; 2003 Mar; 11(3):198-207. PubMed ID: 12623291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
    J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis.
    Doherty NS; Littman BH; Reilly K; Swindell AC; Buss JM; Anderson NL
    Electrophoresis; 1998 Feb; 19(2):355-63. PubMed ID: 9548303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
    McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.
    O'Dell JR; Blakely KW; Mallek JA; Eckhoff PJ; Leff RD; Wees SJ; Sems KM; Fernandez AM; Palmer WR; Klassen LW; Paulsen GA; Haire CE; Moore GF
    Arthritis Rheum; 2001 Oct; 44(10):2235-41. PubMed ID: 11665963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis.
    Haar D; Sølvkjaer M; Unger B; Rasmussen KJ; Christensen L; Hansen TM
    Scand J Rheumatol; 1993; 22(3):113-8. PubMed ID: 8316771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels.
    Dezube BJ; Lederman MM; Chapman B; Georges DL; Dogon AL; Mudido P; Reis-Lishing J; Cheng SL; Silberman SL; Crumpacker CS
    J Infect Dis; 1997 Sep; 176(3):807-10. PubMed ID: 9291340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.
    Hwang YG; Balasubramani GK; Metes ID; Levesque MC; Bridges SL; Moreland LW
    Arthritis Res Ther; 2016 May; 18(1):108. PubMed ID: 27188329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
    Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
    Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.